Topical Antivirals

Topical Antivirals: Basics - Viral Skin Invaders

• Viral Targets:
  • Herpes Simplex Virus (HSV-1, HSV-2): Oral & genital herpes.
  • Varicella-Zoster Virus (VZV): Shingles, chickenpox.
  • Human Papillomavirus (HPV): Warts.
  • 📌 Mnemonic: "Very Happy People" (VZV, HSV, HPV) get topical treatments.
• Advantages:
  • Localized effect: High drug concentration at infection site.
  • Reduced systemic toxicity: Minimal absorption into bloodstream.
  • OTC availability for some (e.g., docosanol for cold sores).
• Limitations:
  • Skin penetration challenges: Stratum corneum acts as a barrier.
  • Viral latency: Ineffective against dormant virus in nerve ganglia (HSV, VZV).

⭐ Topical antivirals are most effective when initiated during the prodromal stage of recurrent infections (e.g., tingling for HSV).

Acyclovir & Penciclovir - Herpes Heroes

📌 'A-P Cycle': Acyclovir/Penciclovir halt herpes. (Context: Valacyclovir→ACV, Famciclovir→PCV are systemic prodrugs).

• MOA: Guanosine analogs activated by viral Thymidine Kinase (TK).

  • $ACV/PCV \xrightarrow{\text{Viral TK}} \text{Monophosphate} \xrightarrow{\text{Host Kinases}} \text{Triphosphate}$
  • Triphosphates then inhibit viral DNA polymerase.

• Spectrum: HSV-1, HSV-2 > VZV.

• Indications (Topical): Herpes labialis (cold sores), initial genital herpes (adjunctive).

• Topical Formulations & Dosing:

  Drug	Acyclovir (ACV)	Penciclovir (PCV)
  Cream Conc.	5%	1%
  Dosing (Labialis)	5 times/day for 4 days	Every 2 hrs (waking) for 4 days

⭐ Penciclovir has a longer intracellular half-life (PCV-TP: 7-20h) vs. Acyclovir (ACV-TP: 0.7-1h), offering sustained viral suppression.

Other Important Agents - Wart Warriors & More

⭐ Imiquimod application can cause flu-like symptoms (fever, chills, myalgia) due to systemic cytokine release, mimicking a viral infection.

Clinical Application & ADRs - Skin Savers' Secrets

• Application Pearls: Apply thin layer to clean, dry, affected skin. Wash hands before & after.

• 📌 Early Bird Catches the Virus: Initiate at first sign (prodrome) for maximal efficacy.

• Adverse Drug Reactions (ADRs):

  • Most Topicals: Local irritation, burning, stinging, erythema, pruritus.

  • Drug-Specific:

    • Imiquimod: Significant local inflammation (erythema, erosions, crusting), hypopigmentation, systemic flu-like symptoms.
    • Podophyllotoxin: Severe local irritation, pain, erosions. ⚠️ Strictly Contraindicated in Pregnancy.

• Resistance Watch:

  • Acyclovir/Penciclovir: Altered/deficient viral Thymidine Kinase (TK) gene is a common mechanism.

⭐ Resistance to acyclovir and related drugs is notably higher and clinically significant in immunocompromised patients (e.g., HIV, transplant recipients).

High‑Yield Points - ⚡ Biggest Takeaways

• Acyclovir/Penciclovir: For HSV/VZV; need viral thymidine kinase. Resistance if kinase altered.
• Docosanol (10%): Fusion inhibitor for orolabial herpes; blocks viral entry. OTC.
• Imiquimod (5%): Immune modulator for HPV warts (anogenital); induces IFN-α. Not direct antiviral.
• Podophyllotoxin (0.5%): Antimitotic for genital warts; highly teratogenic.
• Cidofovir (topical): For acyclovir-resistant HSV in immunocompromised. Nucleotide analog.
• Topical agents: Less potent than systemic. Best for mild, localized infections or prophylaxis_._